Francesca Combi

Delay in Breast Cancer Treatments During the First COVID-19 Lockdown. A Multicentric Analysis of 432 Patients

Gianluca Vanni, Giovanni Tazzioli, Marco Pellicciaro et al. · Anticancer Research · 2020 · 94 citations · Full text

Medicine, Oncology, Surgery +13

Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers

Angela Toss, Elena Tenedini, Claudia Piombino et al. · Genes · 2021 · 29 citations · Full text

Medicine, Oncology, Pathology +16

Low neutrophil-to-lymphocyte ratio and pan-immune-inflammation-value predict nodal pathologic complete response in 1274 breast cancer patients treated with neoadjuvant chemotherapy: a multicenter analysis

Maria Luisa Gasparri, Sara Albasini, Marta Truffi et al. · Therapeutic Advances in Medical Oncology · 2023 · 28 citations · Full text

Medicine, Immunology, Oncology +14

Development of a novel nomogram-based online tool to predict axillary status after neoadjuvant chemotherapy in cN+ breast cancer: A multicentre study on 1,950 patients

Fabio Corsi, Sara Albasini, Luca Sorrentino et al. · The Breast · 2021 · 19 citations · Full text

Medicine, Oncology, Breast Oncology +16

Predictive factors for relapse in triple-negative breast cancer patients without pathological complete response after neoadjuvant chemotherapy

Angela Toss, Marta Venturelli, Monica Civallero et al. · Frontiers in Oncology · 2022 · 17 citations · Full text

Medicine, Oncology, Breast Oncology +16